Form 8-K - Current report:
SEC Accession No. 0001193125-24-231281
Filing Date
2024-10-02
Accepted
2024-10-02 17:20:31
Documents
13
Period of Report
2024-09-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d870918d8k.htm   iXBRL 8-K 44910
  Complete submission text file 0001193125-24-231281.txt   173775

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rphm-20240926.xsd EX-101.SCH 2862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rphm-20240926_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rphm-20240926_pre.xml EX-101.PRE 11715
15 EXTRACTED XBRL INSTANCE DOCUMENT d870918d8k_htm.xml XML 3772
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 241348836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)